SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (3126)6/3/1999 4:21:00 PM
From: RCMac  Read Replies (2) of 10280
 
"Chalk One Up for Sepracor's Shorts" - more shoddy journalism, this time from the 6/21/99 Fortune, and featuring BS's David Maris: pathfinder.com

"'Up until J&J, the majority of people believed that most deals were pretty solid,' says Bear Stearns' David Maris, the only analyst until recently with anything less than a "buy" rating on Sepracor (and now the only one with an outright "sell"). One day after the J&J news, analysts shaved earnings estimates for 2000 by 24 cents, according to First Call. Three Sepracor board members have sold their holdings, and hedge fund manager Mike DiCarlo has completely wiped out his position for now."

Careless, to put it gently, to say the "board members have sold their holdings." In fact, three outside directors have each sold a portion of their holdings, on the order of 30-35% each, and retained more than 20,000 shares each.

--RCM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext